PCA3 and prostate neoplasm: [5] reported that prostate cancer associated 3 (PCA3, also referred to as DD3) and prostate-specific transcript 1 (PCGEM1) were the first lncRNAs that were associated with cancer because of their aberrant expression, found to have differential display analysis of prostate tumours and normal tissue [5].